Qube Research & Technologies (QRT)’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-330,347
| Closed | -$89.2M | – | 2720 |
|
|
2025
Q1 | $89.2M | Sell |
330,347
-154,913
| -32% | -$41.8M | 0.1% | 188 |
|
|
2024
Q4 | $114M | Buy |
485,260
+333,098
| +219% | +$78.4M | 0.15% | 138 |
|
|
2024
Q3 | $41.8M | Buy |
+152,162
| New | +$41.8M | 0.06% | 296 |
|
|
2024
Q2 | – | Sell |
-110,759
| Closed | -$16.6M | – | 3355 |
|
|
2024
Q1 | $16.6M | Buy |
110,759
+92,307
| +500% | +$13.8M | 0.03% | 550 |
|
|
2023
Q4 | $3.53M | Buy |
18,452
+17,452
| +1,745% | +$3.34M | 0.01% | 1029 |
|
|
2023
Q3 | $177K | Buy |
+1,000
| New | +$177K | ﹤0.01% | 2034 |
|
|
2022
Q4 | – | Sell |
-1,453
| Closed | -$291K | – | 2362 |
|
|
2022
Q3 | $291K | Buy |
+1,453
| New | +$291K | ﹤0.01% | 1588 |
|
|
2022
Q2 | – | Sell |
-6,951
| Closed | -$1.14M | – | 2433 |
|
|
2022
Q1 | $1.14M | Buy |
6,951
+3,424
| +97% | +$559K | 0.01% | 1093 |
|
|
2021
Q4 | $598K | Sell |
3,527
-41,372
| -92% | -$7.01M | ﹤0.01% | 1482 |
|
|
2021
Q3 | $8.48M | Buy |
+44,899
| New | +$8.48M | 0.11% | 240 |
|
|
2020
Q3 | – | Sell |
-45,459
| Closed | -$6.73M | – | 1643 |
|
|
2020
Q2 | $6.73M | Buy |
+45,459
| New | +$6.73M | 0.1% | 259 |
|
|
2020
Q1 | – | Sell |
-15,545
| Closed | -$1.79M | – | 1092 |
|
|
2019
Q4 | $1.79M | Buy |
+15,545
| New | +$1.79M | 0.06% | 389 |
|
|
2018
Q4 | – | Sell |
-398
| Closed | -$35K | – | 313 |
|
|
2018
Q3 | $35K | Buy |
+398
| New | +$35K | ﹤0.01% | 919 |
|